Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/19/2006 | US20060234367 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance |
10/19/2006 | US20060234352 Homogeneity and secretion of recombinant proteins in mammalian systems |
10/19/2006 | US20060234344 Protein kinases |
10/19/2006 | US20060234343 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states |
10/19/2006 | US20060234342 Human DNA topoisomerase I alpha |
10/19/2006 | US20060234339 Method of expressing protein having unnatural amino acid integrated thereinto |
10/19/2006 | US20060234311 Isolating cells expressing secreted proteins |
10/19/2006 | US20060234310 Enriched antigen-specific T-cells and related therapeutic and prophylactic compositions and methods |
10/19/2006 | US20060234296 Method for generating high affinity antibodies |
10/19/2006 | US20060234289 Sp110, a polypeptide component of the nuclear body |
10/19/2006 | US20060234280 Enyzmes having alpha amylase activity and methods of making and using them |
10/19/2006 | US20060234275 Method for collecting purified cells |
10/19/2006 | US20060234232 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
10/19/2006 | US20060234217 Nucleic acid encodes a heat labile alkaline phosphatase, or the complementary sequence |
10/19/2006 | US20060234211 Arterivirus (RNA enveloped virus); polypeptides with sensitivity and specificity; decreasing the incidence of false positives in a diagnostic assay |
10/19/2006 | US20060233855 Administering a synthetic polymer ( biodegradable, nonbiodegradable polymers e.g. polylactic acid, PTFE) attached to denatured, uncleaved fibrinogen being subject to proteolytic and hydrolytic degradation in a patient in need of bone tissue, thereby regenerating the bone or cartilage tissues |
10/19/2006 | US20060233854 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
10/19/2006 | US20060233840 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
10/19/2006 | US20060233839 Novel compounds |
10/19/2006 | US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
10/19/2006 | US20060233819 Inhibition of T cell activation by butyrophilin 4 or B7-L1 |
10/19/2006 | US20060233818 Organic compounds |
10/19/2006 | US20060233808 Peptabody for cancer treatment |
10/19/2006 | US20060233802 Tumour necrosis factor binding ligands |
10/19/2006 | US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
10/19/2006 | US20060233796 Method of modulating memory effector T-cells and compositions |
10/19/2006 | US20060233795 Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells |
10/19/2006 | US20060233787 Human cd3-specific antibody with immunosuppressive properties |
10/19/2006 | US20060233771 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
10/19/2006 | US20060233770 a human cell line, which lacks major histocompatibility class I (MHC-I) and class II (MHC-II) antigens, has been modified to comprise and express a nucleotide sequence encoding an immunomodulator, and a nucleotide sequence encoding an antigen of Epstein-Barr virus |
10/19/2006 | US20060233769 Established cell line of microglia |
10/19/2006 | US20060233768 Elective collection and banking of autologous peripheral blood stem cells |
10/19/2006 | US20060233765 Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
10/19/2006 | US20060233764 Skin regeneration system |
10/19/2006 | US20060233763 Cartilaginous cell culture medium and the use thereof |
10/19/2006 | US20060233760 Splicing variant of TGF-beta2 and uses thereof |
10/19/2006 | US20060233758 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
10/19/2006 | US20060233757 Vectors with viral insulators |
10/19/2006 | US20060233751 Population of natural cells, 50% are autoantigen-specific regulatory T cells |
10/19/2006 | US20060233750 Materials and method of modulating the immune response |
10/19/2006 | US20060233745 Enclosures housing cell-coated supports for treating tumors |
10/19/2006 | US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA |
10/19/2006 | DE102005017551A1 Recovery, preparation and storage of stem cells from umbilical cord blood, useful e.g. for autologous treatment of anemias, cancer, AIDS and thalassemia |
10/19/2006 | CA2604697A1 In vitro production of a cell population using feeder cells |
10/19/2006 | CA2604493A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
10/19/2006 | CA2604423A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor |
10/19/2006 | CA2604377A1 Compositions and methods for the diagnosis and treatment of tumor |
10/19/2006 | CA2604330A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
10/19/2006 | CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use |
10/19/2006 | CA2603863A1 Gammaretrovirus associated with cancer |
10/19/2006 | CA2603779A1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
10/19/2006 | CA2603453A1 5-fluorouracil-resistant bacteria and method for production thereof |
10/19/2006 | CA2583027A1 Serum-free cell culture medium for mammalian cells |
10/18/2006 | EP1712631A2 Fc receptors and polypeptides |
10/18/2006 | EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
10/18/2006 | EP1712626A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same |
10/18/2006 | EP1712624A1 Ires functioning in plant |
10/18/2006 | EP1712620A1 Peptide originating in epidermal growth factor receptor (egfr) |
10/18/2006 | EP1712616A1 Induction of myocardial cell with the use of mammalian bone marrow cell or cord blood-origin cell and fat tissue |
10/18/2006 | EP1712615A1 In vitro production of a cell population using feeder cells |
10/18/2006 | EP1712565A1 Cell death inducing agents |
10/18/2006 | EP1712563A1 Method of isolating monocytes |
10/18/2006 | EP1712561A1 Silk thread containing spider thread protein and silkworm producing the silk thread |
10/18/2006 | EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines |
10/18/2006 | EP1711613A2 Gene silencing by using micro-rna molecules |
10/18/2006 | EP1711608A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
10/18/2006 | EP1711599A1 Embryonic stem cell line and method for preparing the same |
10/18/2006 | EP1711598A1 Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof |
10/18/2006 | EP1711597A2 Human hepatic progenitor cells and methods of use thereof |
10/18/2006 | EP1711596A1 A method and apparatus for orienting spherical cells |
10/18/2006 | EP1711595A2 Use of polysulphated alginate in cellular matrices |
10/18/2006 | EP1711594A1 Novel culture systems for ex vivo development |
10/18/2006 | EP1711531A2 Neutralizing antibodies and methods of use thereof |
10/18/2006 | EP1711530A2 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
10/18/2006 | EP1711517A2 MUTANT SODIUM CHANNEL NAv1.7 AND METHODS RELATED THERETO |
10/18/2006 | EP1711052A1 Mouse model for psoriasis and psoriatic arthritis |
10/18/2006 | EP1556481B1 Method for activating dendritic cells |
10/18/2006 | EP1543329A4 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
10/18/2006 | EP1527158B1 Advanced roller bottle system for cell and tissue culturing |
10/18/2006 | EP1481063B1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils |
10/18/2006 | EP1448595B1 Antimicrobial polypeptides from pseudoplectania nigrella |
10/18/2006 | EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
10/18/2006 | EP1358332B1 A serpin in bifidobacteria |
10/18/2006 | EP1337636B1 Soluble zcytor 11 cytokine receptors |
10/18/2006 | EP1326654B1 Methods and compositions for tissue regeneration |
10/18/2006 | EP1280821B1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis |
10/18/2006 | EP1272203B1 Treatment of neurodegenerative gastrointestinal disorders by implanting neural stem cells and/or progeny thereof into gastrointestinal organs |
10/18/2006 | EP1262557B1 Parkin protein as ubiquitin ligase |
10/18/2006 | EP1210411B1 Compositions and methods for improved cell culture |
10/18/2006 | EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
10/18/2006 | EP1165778B1 Uses of casb618 polynucleotides and polypeptides |
10/18/2006 | EP1144666B1 Replication deficient baculovirus expression system |
10/18/2006 | EP1144611B1 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
10/18/2006 | EP1141286B1 Cytokine receptor chain |
10/18/2006 | EP1131434B1 Apoptosis-inducing factor |
10/18/2006 | EP1119611B1 Composition for use in chemonucleolysis |
10/18/2006 | EP1071710B1 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
10/18/2006 | EP1042468B1 Low-voltage activated calcium channel compositions and methods |
10/18/2006 | EP1038008B1 Methods for producing egiii-like enzymes |
10/18/2006 | EP1019500B1 Ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |